Compare CRIS & GENK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRIS | GENK |
|---|---|---|
| Founded | 2000 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9M | 14.1M |
| IPO Year | 2000 | 2023 |
| Metric | CRIS | GENK |
|---|---|---|
| Price | $1.10 | $1.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $16.50 | $5.67 |
| AVG Volume (30 Days) | ★ 214.6K | 46.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.71% |
| EPS Growth | 23.21 | ★ 62.50 |
| EPS | N/A | ★ N/A |
| Revenue | $9,898,000.00 | ★ $208,380,000.00 |
| Revenue This Year | $6.13 | $8.46 |
| Revenue Next Year | $7.86 | $8.17 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 31.50 | 15.12 |
| 52 Week Low | $0.77 | $1.66 |
| 52 Week High | $3.18 | $7.39 |
| Indicator | CRIS | GENK |
|---|---|---|
| Relative Strength Index (RSI) | 56.59 | 29.19 |
| Support Level | $1.06 | N/A |
| Resistance Level | $1.21 | $2.55 |
| Average True Range (ATR) | 0.10 | 0.12 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 70.90 | 13.28 |
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
GEN Restaurant Group Inc operates an Asian casual dining restaurant chain, offering an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables. It operates 43 Gen Korean BBQ restaurants in the United States.